OrbitalRX
PrivateLast Round
Series A
May 26, 2023
Total Funding Raised
$5.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
OrbitalRX operates in Healthcare & Life Sciences and is based in Winston-Salem, North Carolina. Its latest recorded funding round was a Series A round in May 2023.
OrbitalRX is a healthcare technology company that provides a drug shortage management software designed to assist hospital pharmacy teams in improving medication shortages.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OrbitalRX Comparables
Compare OrbitalRX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quva | 82% | |
| Bluesight | 81% | |
| GHX Europe | 75% |
For institutional investors. Book with your work email.
OrbitalRX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 26, 2023 | ||||
| Seed | Mar 1, 2021 | ||||
| Seed | Aug 28, 2019 | ||||
| Seed | Oct 5, 2018 | ||||
| Accelerator | May 28, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OrbitalRX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alerion Ventures | Seed |
| Hatteras Venture Partners | Seed |
| New Ventures (North Carolina) | Accelerator |
| The Launch Place | Seed |
| Boston Millennia Partners | Seed |
| Excelerate Health Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 728% MoM.
- Apr 16, 2026
Monthly visitors increased 40% MoM, reaching 1.4K.
For institutional investors. Book with your work email.
OrbitalRX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OrbitalRX's valuation, stock price, and market status.
Is OrbitalRX a public or private company?
OrbitalRX is a private company.
What is the current stock price of OrbitalRX?
OrbitalRX is a private company, so its shares have no public market price. Caplight tracks OrbitalRX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OrbitalRX worth (valuation)?
Valuation information for OrbitalRX is not publicly available.
Can I buy OrbitalRX stock?
OrbitalRX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OrbitalRX's last funding round?
OrbitalRX's most recent funding round was Series A on May 26, 2023.
Who are the main investors in OrbitalRX?
Key investors in OrbitalRX include The Launch Place, Excelerate Health Ventures.
Will OrbitalRX IPO soon?
No public IPO plans have been announced for OrbitalRX.
How can I track OrbitalRX secondary market activity?
Caplight tracks bids, offers, and trades in OrbitalRX's shares on secondary markets.